Response to Capmatinib in a MET Fusion-positive Cholangiocarcinoma
The Oncologist（2022）
Key words
MET,cholangiocarcinoma,resistance,precision medicine
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined